Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

Published:2018-01-19 Issue:1 Volume:20 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Busby John^ORCID,Mills Ken,Zhang Shu-Dong,Liberante Fabio Giuseppe,Cardwell Chris R.

Funder

Cancer Research UK

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-017-0928-0.pdf

Reference61 articles.

1. Cancer Registration Statistics 2014, England. http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2014 . Accessed 4 May 2017.

2. Globocan. Estimated Cancer Incidence, Mortaility and Prevelence Worldwide in 2012. ttp://globocan.iarc.fr . Accessed 30 May 2017.

3. Cancer survival in England: Patients diagnosed between 2010 and 2014 and followed up to 2015. http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancersurvivalinenglandadultsdiagnosed/2010and2014andfollowedupto2015 . Accessed 24 Feb 2017.

4. Blair CK, Robien K, Inoue-Choi M, Rahn W, Lazovich D. Physical inactivity and risk of poor quality of life among elderly cancer survivors compared to women without cancer: the Iowa Women's Health Study. J Cancer Surviv Res Pract. 2016;10(1):103–12.

5. Klein D, Mercier M, Abeilard E, Puyraveau M, Danzon A, Dalstein V, Pozet A, Guizard AV, Henry-Amar M, Velten M. Long-term quality of life after breast cancer: a French registry-based controlled study. Breast Cancer Res Treat. 2011;129(1):125–34.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data;Cancer Epidemiology;2023-10

2. Imipramine Induces Apoptosis and Inhibits the Metastatic Potential of Triple-negative Breast Cancer Cells;Anticancer Research;2023-06-23

3. Letter to the Editor of Clinical Breast Cancer, on “Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review,” Conducted by Michelle Bradbury and Collaborators and Published in Clinical Breast Cancer April Vol 22 no.4 e362-e373, 2022;Clinical Breast Cancer;2023-04

4. Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR;Frontiers in Global Women's Health;2022-12-08

5. Stress and cancer: The mechanisms of immune dysregulation and management;Frontiers in Immunology;2022-10-05